| pubmed-article:9633736 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9633736 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:9633736 | lifeskim:mentions | umls-concept:C0025815 | lld:lifeskim |
| pubmed-article:9633736 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:9633736 | lifeskim:mentions | umls-concept:C0444956 | lld:lifeskim |
| pubmed-article:9633736 | lifeskim:mentions | umls-concept:C0024485 | lld:lifeskim |
| pubmed-article:9633736 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:9633736 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:9633736 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:9633736 | pubmed:dateCreated | 1998-7-9 | lld:pubmed |
| pubmed-article:9633736 | pubmed:abstractText | To assess the efficacy of two different high doses of intravenous methylprednisolone (IVMP) for the treatment of relapses in MS. | lld:pubmed |
| pubmed-article:9633736 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9633736 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9633736 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9633736 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9633736 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9633736 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9633736 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:9633736 | pubmed:issn | 0028-3878 | lld:pubmed |
| pubmed-article:9633736 | pubmed:author | pubmed-author:QuattroneAA | lld:pubmed |
| pubmed-article:9633736 | pubmed:author | pubmed-author:GambardellaAA | lld:pubmed |
| pubmed-article:9633736 | pubmed:author | pubmed-author:ValentinoPP | lld:pubmed |
| pubmed-article:9633736 | pubmed:author | pubmed-author:PardatscherKK | lld:pubmed |
| pubmed-article:9633736 | pubmed:author | pubmed-author:AgugliaUU | lld:pubmed |
| pubmed-article:9633736 | pubmed:author | pubmed-author:BonoFF | lld:pubmed |
| pubmed-article:9633736 | pubmed:author | pubmed-author:RussoCC | lld:pubmed |
| pubmed-article:9633736 | pubmed:author | pubmed-author:FermRR | lld:pubmed |
| pubmed-article:9633736 | pubmed:author | pubmed-author:ZappiaMM | lld:pubmed |
| pubmed-article:9633736 | pubmed:author | pubmed-author:OliveriR LRL | lld:pubmed |
| pubmed-article:9633736 | pubmed:author | pubmed-author:SibiliaGG | lld:pubmed |
| pubmed-article:9633736 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9633736 | pubmed:volume | 50 | lld:pubmed |
| pubmed-article:9633736 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9633736 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9633736 | pubmed:pagination | 1833-6 | lld:pubmed |
| pubmed-article:9633736 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9633736 | pubmed:meshHeading | pubmed-meshheading:9633736-... | lld:pubmed |
| pubmed-article:9633736 | pubmed:meshHeading | pubmed-meshheading:9633736-... | lld:pubmed |
| pubmed-article:9633736 | pubmed:meshHeading | pubmed-meshheading:9633736-... | lld:pubmed |
| pubmed-article:9633736 | pubmed:meshHeading | pubmed-meshheading:9633736-... | lld:pubmed |
| pubmed-article:9633736 | pubmed:meshHeading | pubmed-meshheading:9633736-... | lld:pubmed |
| pubmed-article:9633736 | pubmed:meshHeading | pubmed-meshheading:9633736-... | lld:pubmed |
| pubmed-article:9633736 | pubmed:meshHeading | pubmed-meshheading:9633736-... | lld:pubmed |
| pubmed-article:9633736 | pubmed:meshHeading | pubmed-meshheading:9633736-... | lld:pubmed |
| pubmed-article:9633736 | pubmed:meshHeading | pubmed-meshheading:9633736-... | lld:pubmed |
| pubmed-article:9633736 | pubmed:meshHeading | pubmed-meshheading:9633736-... | lld:pubmed |
| pubmed-article:9633736 | pubmed:meshHeading | pubmed-meshheading:9633736-... | lld:pubmed |
| pubmed-article:9633736 | pubmed:meshHeading | pubmed-meshheading:9633736-... | lld:pubmed |
| pubmed-article:9633736 | pubmed:meshHeading | pubmed-meshheading:9633736-... | lld:pubmed |
| pubmed-article:9633736 | pubmed:meshHeading | pubmed-meshheading:9633736-... | lld:pubmed |
| pubmed-article:9633736 | pubmed:meshHeading | pubmed-meshheading:9633736-... | lld:pubmed |
| pubmed-article:9633736 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9633736 | pubmed:articleTitle | Randomized trial comparing two different high doses of methylprednisolone in MS: a clinical and MRI study. | lld:pubmed |
| pubmed-article:9633736 | pubmed:affiliation | Unit of Neurology, Faculty of Medicine, Catanzaro, Italy. | lld:pubmed |
| pubmed-article:9633736 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9633736 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9633736 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:9633736 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9633736 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9633736 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9633736 | lld:pubmed |
